Kent Wallner is an Oncology physician affiliated with University of Washington. OpenAlex indexes 450 publications with 12,761 citations (h-index 58); ClinicalTrials.gov lists 6 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Radiation Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1660 S Columbian Way
Ms 174
Seattle, WA 981081532
Telephone
206-768-5356Registry record last updated 8 Jul 2007.
Clinical trials
- High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer
Sponsor: VA Puget Sound Health Care System
- I-125 Versus Pd-103 for Low Risk Prostate Cancer
Sponsor: VA Puget Sound Health Care System
- I-125 Versus Pd-103 for Medium Risk Prostate Cancer
Sponsor: VA Puget Sound Health Care System
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bard Peripheral Vascular, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Genitourinary & hormones
100%alpha-Adrenergic Blocker100%Tamsulosin Hcl77%Terazosin Hcl23%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Long-Term Outcome for Clinically Localized Prostate Cancer Treated With Permanent Interstitial Brachytherapy
International Journal of Radiation Oncology*Biology*Physics
2010 - Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting
Prostate Cancer and Prostatic Diseases
2009 - Natural History of Clinically Staged Low- and Intermediate-Risk Prostate Cancer Treated With Monotherapeutic Permanent Interstitial Brachytherapy
International Journal of Radiation Oncology*Biology*Physics
2009 - The morbidity of transperineal template‐guided prostate mapping biopsy
British Journal of Urology
2008
Similar KOLs
Other experts from the same institution or the same specialty.
Neal Futran, MD, DMD
University of Washington
Elizabeth Swisher
University of Washington
David Tirschwell
University of Washington
Elaine Peskind, MD
University of Washington
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”